Saeki, H., Nakagawa, H., Nakajo, K., Ishii, T., Morisaki, Y., Aoki, T., . . . Yamanaka, K. (2016). Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52‐week, open‐label, phase 3 study (UNCOVER‐J). J Dermatol.
Citação norma ChicagoSaeki, Hidehisa, et al. "Efficacy and Safety of Ixekizumab Treatment for Japanese Patients With Moderate to Severe Plaque Psoriasis, Erythrodermic Psoriasis and Generalized Pustular Psoriasis: Results From a 52‐week, Open‐label, Phase 3 Study (UNCOVER‐J)." J Dermatol 2016.
MLA引文Saeki, Hidehisa, et al. "Efficacy and Safety of Ixekizumab Treatment for Japanese Patients With Moderate to Severe Plaque Psoriasis, Erythrodermic Psoriasis and Generalized Pustular Psoriasis: Results From a 52‐week, Open‐label, Phase 3 Study (UNCOVER‐J)." J Dermatol 2016.